Format

Send to

Choose Destination
Breast J. 2009 Jan-Feb;15(1):4-16. doi: 10.1111/j.1524-4741.2008.00665.x.

Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.

Author information

1
Jefferson Medical College, 1015 Chestnut Street, Suite 510, Philadelphia, PA 19107-4305, USA. gordonschwartz@yahoo.com

Abstract

A consensus conference including thirty experts was held in April, 2007, to discuss risk factors for breast cancer and their management. Four categories of risk were outlined, from breast cancer "average" through "very high" risk, the latter including individuals with high penetrance BRCA1/2 gene mutations. Guidelines for management of patients in each of these categories were discussed, with the major portion of the conference being devoted to individuals with BRCA1/2 mutations. Prevalence of these mutations in the general populations was estimated to be 1 in 250-500 individuals, with an increased prevalence in Ashkenazic Jews and other founder groups. Risk reduction strategies for these individuals include surveillance, with or without chemoprevention drugs, or surgical procedures to remove the organs at risk, i.e., bilateral mastectomy and/or bilateral salpingo-oophorectomy. These risk reduction strategies were evaluated fully, and recommendations were made for the care of patients in each of the risk categories. These guidelines for patient care were approved by the entire group of experts.

PMID:
19141130
PMCID:
PMC3756316
DOI:
10.1111/j.1524-4741.2008.00665.x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center